AIDS Weekly articles from October 2000

AIDS Weekly archives from October 2000

Early Antiviral Treatment Primes Immune System to Suppress Viral Levels Without Drugs.
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- A research team from Massachusetts General Hospital (MGH) has shown that the majority of HIV infected individuals who begin antiviral therapy during the earliest stages of their infection eventually can stop...

AIDSVAX B/E Reported Safe and Highly Immunogenic in Volunteers.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- The bivalent B/E rgp120 HIV vaccine (AIDSVAX B/E) was observed to be safe and highly immunogenic in volunteers, researchers from Thailand and the United States reported. The researchers assessed "safety...

Brain Choline Acetyltransferase Levels Reduced in Early Infection.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Reduced levels of brain choline acetyltransferase were found in early stages of simian immunodeficiency virus infection in a monkey model of HIV infection, researchers in Germany reported. "HIV infection...

Lymphoproliferative Responses are Measure of Therapeutic Success.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Improved lymphoproliferative responses (LPRs) are indicative of the success of highly active antiretroviral therapy (HAART) on T-cell immune function, researchers in Bulgaria have found. "Current interest...

Patients Getting HIV Drug Resistance Genotyping Fare Better.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Updated Narval data presented during the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in Toronto, Ontario, Canada, during September 2000, showed a better long term...

Study Evaluates Dosage Adjustments of Amprenavir.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- A study that evaluated dosage adjustments of the protease inhibitor (PI) Agenerase(R) (amprenavir) capsules in HIV patients treated with efavirenz or nevirapine, antiretroviral (ART) agents known to affect the...

HIV-2 Infection Present in Guinea-Bissau Since the Early 1980s.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Research from Portugal suggests that HIV-2 infection has been present in West Africa since the early 1980s. "We have retrospectively studied the seroprevalence of the human immunodeficiency virus (HIV) in...

Scientists Reveal Possible New Target.(using early killer T-cell immune responses to help combat HIV infection)(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Scientists have shown for the first time, using a non-human primate model, that HIV avoids the body's strongest immune responses during the first few weeks of infection. The finding, which appeared in the...

High-Dose Chemotherapy/Autologous Stem Cell Transplantation Effective.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- High-dose chemotherapy supported by autologous stem cell transplantation is a safe and effective therapy for HIV infected patients with non-Hodgkin's lymphoma, suggest recent study results. "The advent of...

Optimal Immune Function Requires Virus-Specific Cytotoxic T Lymphocyte Responses.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- According to researchers in the United Kingdom, optimal immune responses against HIV-1 infection require the help of virus-specific cytotoxic T lymphocytes (CTL). "Virus-specific CD8(+) CTLs play a central...

High Rate of Heart-Related Deaths Found in HIV Infected Children.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- For the first time researchers have linked heart failure to increased risk of death in children with HIV, according to a study in the September 26, 2000, issue of Circulation. The study shows that heart...

Costs of Treating Abnormal Fat Distribution and Metabolic Abnormalities Outlined.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- The first-year costs to manage a single symptom of an increasingly common complication associated with HIV/AIDS therapy could range from $410 to $7,369 per patient, according to a pharmacoeconomic modeling...

Frequently Monitored Patients Show Better Suppression of HIV Viral Load.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Laboratory Corp. of America Holdings (LH) (LabCorp), Burlington, North Carolina, presented its latest findings on HIV viral load trends in the United States at the Interscience Conference on Antimicrobial...

HIV Drug Candidate Shown Effective in Preclinical Studies.(AMD-8664)(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Data on an orally-administered drug candidate with the potential to block HIV from entering and infecting healthy T cells were presented by AnorMED Inc. (AOM) at the 40th Interscience Conference on...

No Difference in Adherence to Once or Twice Daily Dosing Indicated in Survey.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Roche Pharmaceuticals reported results from a survey that showed no difference in adherence to therapy between twice-daily (BID) and once-daily (QD) dosing regimens among people living with HIV. The survey...

Pharmacokinetics Unaffected When Antivirals Used with Selective Reuptake Inhibitors.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Pharmacokinetic data suggest that when selective serotonin reuptake inhibitors (SSRIs) are used at the same time that patients with HIV infection are receiving DuPont Pharmaceuticals' Sustiva (efavirenz),...

South African Health Minister Questions Cause of AIDS.(Manto Tshabalala-Msimang)(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Defying mainstream scientific opinion and dismissing mounting criticism that it is confusing the public, the South African government continued to question whether HIV alone causes AIDS. Health minister...

First MVA Vaccine Cleared for Human Testing.(modified vaccinia Ankara-strain)(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- An AIDS vaccine candidate designed specifically for Africa and manufactured in Germany has been approved for human testing. Wayne Koff, PhD, International AIDS Vaccine Initiative (IAVI), announced that the...

Combination Suppresses Viral Levels in Protease Inhibitor-Naive Patients.(Crixivan; ritonavir)(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Preliminary study results showed Crixivan (indinavir sulfate) administered as an investigational twice-daily 800-mg dose with a low dose of ritonavir (100 mg) suppressed levels of HIV to below the limits of...

Data on Non-Nucleoside Reverse Transcriptase Inhibitor Presented.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Tibotec, Mechelen, Belgium, presented positive results on one of its lead anti-HIV drugs, R165335-TMC125, at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in Toronto,...

Higher RNA Cutoff Needed for HIV-1 Identification in Cerebrospinal Fluid.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- According to a study from Sweden, higher HIV-1 RNA cutoff levels are necessary to positively identify HIV-1 in cerebrospinal fluid (CSF) samples. "HIV-1 can be isolated from the vast majority of blood...

Company Approved to Perform Routine HIV Resistance Testing.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Virco Lab Inc., the U.S. subsidiary of Virco, has successfully passed College of American Pathologists (CAP) and New York State inspections. Accreditation by these bodies means Virco can now provide its...

Interleukin-2 Plus Antiretroviral Therapy Increases CD4(+) Levels.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Preliminary data from the largest clinical trial to date on the safety and efficacy of interleukin-2 (IL-2) in treating people with HIV disease were presented at a late-breaker session of the 40th Interscience...

Immunotherapy Evaluated in SIV Infected Rhesus Macaque Model.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Th1 profiles impact viral replication in DNA vaccinated, simian immunodeficiency virus (SIV) infected Rhesus macaque monkeys, researchers in the United States reported. "A focus of antiretroviral therapy...

Monoclonal Antibodies Bind Primary Isolate Virions.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Monoclonal antibodies that bind and neutralize primary isolate virions may help researchers find new targets for HIV vaccines. "Development of a broadly effective HIV-1 vaccine has been severely limited...

Remune Addition Announced to Treat Primary HIV Infection.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- The Immune Response Corp. (IMNR), Carlsbad, California, announced that Remune (HIV-1 Immunogen), an investigational therapeutic vaccine for the treatment of HIV infection, will be tested as part of a clinical...

Protective Immunity Induced by Engineered Avirulent Virus.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- Researchers in Japan have developed an avirulent virus that successfully induced protective immunity against simian immunodeficiency virus infection in a monkey model. "In AIDS vaccine strategies, live...

HIV and Herpesvirus Vaccines Based on Cloning Viral Envelope Proteins.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- The same principle used to develop the first successful herpes vaccine was also used to develop a preventive HIV/AIDS vaccine currently in the final stage of clinical testing. Both vaccines were produced...

WHO Issues Statement on Hypothesis that Experimental Polio Vaccine Was Origin of HIV.(Brief Article)
October 2, 2000... 2000 OCT 2 - (NewsRx.com) -- The following was released by the World Health Organization on September 12, 2000: [helv] Since the beginning of the AIDS epidemic, there has been much speculation in both the scientific literature and in...

Dietary Supplement Keeps Immune System Balanced in HIV Patients.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Patients infected with the human immunodeficiency virus (HIV) who receive a daily dose of a dietary supplement can boost their levels of glutathione - a nutrient essential for proper functioning of the immune...

Oral Infections Predictive of Immune Suppression and Viral Burden.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Oral opportunistic infections are predictive of the degree of immune suppression and viral load in adults with HIV/AIDS, researchers in the United States report. "The purpose of this study was to assess...

Researchers Battle Drug-Resistant HIV on Promising New Ground.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Researchers believe they have found a promising new battleground for HIV, the virus that causes AIDS: a portion of the virus that is unaffected by its myriad mutations. The findings were described in the...

Multidrug-Resistant TB Can Cause Reinfection in HIV Patients.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Multidrug-resistant tuberculosis was responsible for reinfection of HIV patients in Spain. Researchers conducted a study to analyze "the frequency of reinfection in an outbreak of tuberculosis caused by a...

Nucleotide-Enriched Formula Helps Infants Born to HIV Infected Mothers.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- A nucleotide-enriched formula improves weight gain in infants born to HIV infected mothers, researchers in Italy reported. "Infants born to HIV infected mothers have shown some growth impairments in the...

Clearance Received to Initiate Additional Trials for HIV Immunotherapy.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Hollis-Eden Pharmaceuticals, Inc. (HEPH), San Diego, California, announced clearance from the South African Medicines Control Council (MCC) for the company to initiate additional clinical studies in HIV...

Peer-to-Peer Computing Can Help Speed Pace of AIDS Drug Research.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- To accelerate the discovery of drugs to fight HIV and AIDS, Entropia, Inc., the company creating the world's largest Internet- and Enterprise-distributed computing service, and the Olson laboratory at The...

Oregon May Change AIDS Reporting Policy.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Oregon health officials want to revise AIDS reporting to include diagnoses of HIV - and patient names. Health officials say too many people are diagnosed with HIV but go undocumented, meaning there are...

NIH Grant Supports Anti-HIV Drug Discovery Program.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Salus Therapeutics Inc. announced that the company has received a $96,600 Phase I Small Business Innovation Research (SBIR) grant award from the National Institute of Allergy and Infectious Diseases of the...

Students Learn of AIDS Threat, Less About Protection.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- A girl in Matthew Wentzel's class of ninth-graders at Minnie Howard School, Alexandria, Virginia, wanted to know who gets HIV/AIDS. "Gay people do," said a 15-year-old classmate in the back. When Wentzel...

NIH Grant Awarded to Study HIV Pathogenesis, Latency, and Prevention.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- The Johns Hopkins Center for AIDS Research, Baltimore, Maryland, will receive more than $7.3 million in U.S. government money over five years to study the disease that has killed more than 16 million people...

"Realities" of AIDS Epidemic Shared at Institute of Human Virology Meeting.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- While the HIV virus continues to attack without discrimination, the whole world shares a moral imperative to help places hardest hit by the AIDS epidemic. That clear "take home message" from AIDS-fighting...

South African Government Could Be Sued for Refusing to Provide AIDS Drugs.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- South Africa's Human Rights Commission said it is considering legal action to clarify the government's responsibilities in providing medication to people infected with HIV. The government repeatedly has...

Judge Rules New York City Mistreated Poor with AIDS.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- A U.S. federal judge has ruled the New York City mistreated poor people with AIDS by subjecting them to bureaucratic mismanagement and delays in housing, health, and other benefits. In a decision handed...

HIV TAT Basic Peptide Binds VEGF Receptors 1 and 2.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- HIV TAT basic peptide binds vascular endothelial growth factor (VEGF) receptors 1 and 2, researchers in Switzerland reported. "HIV expresses a multifunctional protein called TAT whose function in vivo is...

Study Appears to Show Why Muscle Decays Mysteriously in Cancer, AIDS, Other Illnesses.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- University of North Carolina at Chapel Hill scientists believe they have discovered a major reason why muscles often decay in patients with cancer, AIDS, late-stage heart disease, severe burns, and numerous...

Researchers to Determine if Anti-Inflammatories are Useful for AIDS Dementia, Alzheimer's.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- There's a marker found in the blood of patients with both Alzheimer's disease and AIDS dementia, and recent research shows it's an inflammatory marker. This raises the question of whether...

Committee Calls for Improved Tracking, Action to Cut Rate of New HIV Infections.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- U.S. efforts to thwart the spread of HIV - the virus that causes AIDS - have slowed rapid growth of the epidemic, but the number of new infections remains unacceptably high, a national committee has...

Antiviral and Anti-Inflammatory Experimental Drug Licensed.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Cytokine PharmaSciences, Inc. (CPSI) and Axxima(R) Pharmaceuticals AG announced that CPSI has granted Axxima exclusive rights to its experimental drug, CNI-1493, in the field of infectious diseases. This...

SangStat Receives NIH Grant for Study of RDP58 in Primate Model of HIV Infection.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- SangStat, The Transplant Company(R) (SANG), announced that it has been awarded a U.S. National Institutes of Health (NIH) Small Business Innovation Research grant to study the effect of RDP58 therapy in simian...

Tuberculosis On the Rise in HIV Infected Children in New York City.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- According to a study from the United States, tuberculosis has increased in HIV infected children in New York city. "Tuberculosis disease incidence increased sharply in New York City (NYC) in the late...

Antisense Enables Long-Term Survival of Transduced Immune Cells.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Long-term survival of therapeutic gene transduced CD34(+) cells in peripheral blood stem cell (PBSC) was realized in a study involving HIV-1 infected patients. D. Liu and colleagues from Enzo...

HIV-1 Immunogen Stimulates HIV Specific Responses.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Treatment with an HIV-1 immunogen resulted in cell-mediated immune responses in HIV infected patients. "We hypothesized that an HIV-1 immunogen (whole-killed gp120-depleted HIV-1 in IFA, Remune), which...

Antiretroviral Therapy Reduces Cytomegalovirus in HIV-1 Patients.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Antiretroviral therapy appears to reduce the number of cytomegalovirus (CMV) infected cells in HIV-1 infected patients. "Visualization of antigen-specific T cells has become an important tool in studying...

Conjugate Vaccines May Be More Effective than Polysaccharide Vaccines in HIV Patients.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Depending on HIV serotype, a 7-valent pneumococcal conjugate vaccine was more protective than a 23-valent polysaccharide vaccine in HIV infected adults, researchers in the United States found. "HIV...

Inconsistent Condom Use in Nigeria Puts Wives at More Risk than Sex Workers.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Nigerian men use condoms more often with commercial sex workers than they do with casual sexual partners or with their wives, a new study finds. As a result, men and women may be more vulnerable to sexually...

Mechanism of Action Discovered.(Brief Article)
October 16, 2000... 2000 OCT 16 - (NewsRx.com) -- Researchers at the University of Amsterdam have made an important step in understanding why the drug thalidomide is such an effective therapy for patients with HIV or mycobacteria infections. They...

Engineered Red Blood Cells Act as Decoys for HIV.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Genetically engineering red blood cells to express the CD4 receptor may be a way to "fool" HIV in vivo, researchers in Australia suggest. "Early stages of HIV infection are associated with an acute phase...

Early Treatment of HIV: Is it Good or Bad?(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Early treatment of HIV may improve life expectancy, but it comes with associated adverse quality of life effects and high monetary costs, researchers in the United States and Canada point out. "The...

Shorter AZT Treatment Reduces Mother-to-Child HIV Transmission.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- A shorter course of zidovudine (AZT) therapy than currently prescribed for HIV infected pregnant women may allow women in developing countries to afford the treatment that can reduce their babies' chances of...

Tenofovir (PMPA) Passes Phase II Clinical Trial Stage.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Tenofovir (PMPA) has antiviral activity against nucleoside-resistant strains of HIV, according to new study findings. M.D. Miller, of Gilead Sciences, California, along with colleagues in the U.S., U.K.,...

Tuberculosis Now Most Common Opportunistic Infection in HIV Patients.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Marked decreases in the incidence of Mycobacterium tuberculosis (TB) and M. avium complex (MAC), common opportunistic infections among human immunodeficiency virus (HIV) infected patients, took place among...

Reporting By Name Does Not Deter Testing.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- A state's policy on HIV reporting by name does not deter high-risk persons from testing, according to a University of California, San Francisco, study. "Name-based HIV reporting is controversial in the...

Post-HIV-Seroconversion Risk is Stable.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- The risk of developing Kaposi's sarcoma after seroconverting to HIV has remained stable over the years, an epidemiological study from Italy has found. G. Rezza and colleagues, Ist Super Sanita, AIDS & STD...

HIV-1 Infected Patients Genotyped After Blood Exposure.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Researchers in France evaluated antiretroviral drug resistance patterns in HIV-1 infected patients involved in occupational exposure of hospital workers. "An association of two nucleoside analogues (NRTI)...

HIV Infected Children Frequently Experience Audiologic Disorders.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Children with HIV infection often experience hearing loss. "About 10% of adult patients with HIV-1 infection have otoneurological (OTN) symptoms," stated M.S. Montalvo and colleagues from the Instituto...

HIV-1 CCR5 Genotype is Less Infective in Mother-to-Child Transmission.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Researchers in Italy who examined HIV-1 genotypes for rates of transmission from mother-to-child found that the CCR5 genotype is less infective. L. Ometto and colleagues at the University of Padua...

Nevirapine Resistance Identified After One Dose in HIV(+) Ugandan Women.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- According to a study from the United States, one dose of nevirapine (NVP) given to Ugandan women during delivery to prevent vertical HIV-1 transmission to their children resulted in a K103N resistance...

Semen Processing Methods Adequate for Eliminating HIV-1.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Semen processing methods incorporating swim-up separation are effective at eliminating HIV-1 from semen of HIV-1 infected men, say researchers in Japan. "Whether artificial insemination can provide...

Ukraine's Capital Develops Program to Combat AIDS.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Authorities in Ukraine's capital Kiev are preparing a comprehensive five-year program to combat AIDS, saying they are alarmed by the spread of the disease in the city, a news agency said October 6, 2000. ...

Prevention, Comprehensive Treatment Urged by Health Ministers at PAHO Meeting.(Pan American Health Organization)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Ministers of Health urged all countries in the Americas to use comprehensive approaches to prevent AIDS and offer access to treatment including antiretroviral drugs for all people with HIV/AIDS in their...

Needle-Exchange Program Follow-up Shows Some Risky Practices Continue Unabated.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- A follow-up study of a major Seattle, Washington, needle exchange program reports that needle exchange significantly correlates with not re-using a used needle to inject drugs, but does not necessarily limit...

Scientists Discover New Molecule of Immune System that Binds an HIV Co-Receptor.(chemokine protein)(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- A team of scientists at the University of California, San Francisco, and Compugen, Ltd., has discovered a new molecule of the immune system - a member of a family of proteins called chemokines which recruit...

Investigators Examine Nature of Tuberculosis Patients Who Fail Therapy.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Factors associated with multi-drug resistant tuberculosis (MDRTB) were recently outlined by public health researchers from New York at the 38(th) Annual Meeting of the Infectious Diseases of America...

U.S. Minorities with HIV Outnumber Whites.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Blacks and Hispanics accounted for nearly 70% of new HIV infections from July 1999 to June 2000 in the U.S., a striking change in what was once known as a disease of gay white men, the U.S. surgeon general...

European Commission, WHO, and UNAIDS Take United Stand Against Killer Diseases.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- The European Commission, the World Health Organization, and the Joint United Nations Program on HIV/AIDS announced a common stand against the epidemics of HIV/AIDS, malaria, and tuberculosis in the developing...

Anti-CD45RO Immunotoxin Eliminates Latently Infected CD4(+) Cells.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Researchers in the United States demonstrated that an anti-CD45RO immunotoxin was able to eliminate latently infected CD4(+) cells from HIV infected patients. "Several studies have demonstrated that...

HIV-1 Envelope-Specific Lymphocytes Stimulated by Semi-Allogeneic Cell Hybrids.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- According to a study from the United States, semi-allogeneic cell hybrids stimulated HIV-1 envelope-specific cytotoxic T lymphocytes (CTL) in vitro. "The present study was designed to determine whether...

HIV-1 Plasmid Antigens and IL-12-Expressing Plasmids Key Components.(interleukin-12)(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- In a recent study, researchers in the United States observed transient declines in viral load in HIV-1 infected chimpanzees vaccinated with HIV-1 DNA vaccines. J.D. Boyer and colleagues, University of...

Recombinant gp160 Stimulates Immune Responses in Adults With Advanced Infection.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- A recombinant HIV-1 gp160 vaccine was well tolerated and stimulated immune responses in adults with advanced HIV infection, health officials in Massachusetts reported. In a study of the "immunogenicity of...

Blood and Semen Correlate, But Blood and Saliva Do Not.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Researchers in France found that compartmentalization of HIV viral loads correlate between blood and semen, but not between blood and saliva. "The aim of this cross-sectional study was to assess the...

HAART Reduces Incidence of HPV Infection in HIV Infected Women.(human papillomavirus infection)(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Highly active antiretroviral therapy (HAART) given to HIV infected women reduces the incidence of human papillomavirus (HPV) infection and resultant cytological abnormalities, researchers in the United States...

Anti-HIV gp160 (Env) Antibodies Respond to HAART.(Brief Article)
October 30, 2000... 2000 OCT 30 - (NewsRx.com) -- Highly active antiretroviral therapy (HAART) may enhance HIV specific humoral immunity by increasing anti-HIV gp160 (Env) antibodies, according to a study from the United Kingdom. "Reconstitution of...